24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
(361)575-0611
(800)421-8825
Fax: (361)578-5500

Medical Disorders
Resources
Basic InformationLookupsLatest News
Global Coronavirus Outbreaks Raise Fears of PandemicGlobal Coronavirus Outbreaks Worry Experts, as U.S. Cases Reach 34Sticking With Meds Lowers Lupus Patients' Diabetes RiskU.S. Coronavirus Cases Reach 34: CDCAHA News: Research Opens New Avenues to Reduce Foot, Toe AmputationsYour Best Bet Against Heart Attack, Stroke? Lower Blood PressureLung Diseases on the Rise WorldwideNew China Coronavirus Cases Decline, 2 Passengers From Affected Cruise Ship DieAHA News: What Women Need to Know About Breast Cancer and Heart DiseaseU.S. Scientists Take Key Step Towards Towards Coronavirus VaccineQuarantine Ends on Cruise Ship in Japan as Coronavirus Cases Near 75,000AHA News: Race and Gender May Tip the Scales on Traditional Stroke Risk FactorsMeasles Complications Can Affect Every Organ: StudyBabies' Exposure to Household Cleaning Products Tied to Later Asthma RiskCoronavirus: Are U.S. Hospitals Prepared?14 Americans From Cruise Ship Hit By Coronavirus Test Positive for InfectionHot Chocolate Could Help Ease Painful Clogged Leg VesselsAntiviral Drug, Plasma Transfusions Show Promise in Treating CoronavirusHow to Dispel Your Child's Fears About the New CoronavirusCholesterol Drugs Might Help Curb 'High-Risk' Prostate CancersCoronavirus Spreads Most Easily When Patients Are Sickest: CDCWill Brushing and Flossing Protect You Against Stroke?Young Black Adults More Prone to Stroke, but Don't Know ItAHA News: Stroke Rates Down for Mexican Americans, Up for White AdultsCoronavirus Cases, Deaths Rise Sharply, While 2 New Cases Reported in U.S.Scientists Spot Antibody That Might Help Diagnose, Treat Autoimmune DisordersCoronavirus in America: Keep Your Panic in CheckCoronavirus Spread Slows, But Death Toll Jumps to 1,113Growing Up in U.S. 'Stroke Belt' Bad for the Brain Later in LifeShingles Vaccine Bonus: Reduced Risk of Stroke?Air Pollution Made in One State Can Cause Deaths in OthersWere You Born in an H1N1 Flu Year or an H3N2? It MattersStricter Clean Air Laws Could Save Thousands of Lives a Year: StudyCoronavirus Fears Have U.S. Pharmacies Running Out of Face MasksCoronavirus Death Toll Tops 1,000, While 13th U.S. Case ConfirmedMeds May Not Prevent Migraines in KidsHigh Testosterone Levels Have Different Health Impact for Men and WomenCoronavirus Cases Top 40,000, While Deaths Hit 908With Macular Degeneration, 1 Missed Visit to Eye Doc Can Mean Vision LossHundreds Suspected, 12 Confirmed: How CDC Identified U.S. Coronavirus CasesFor Patients on Blood Thinners, GI Bleeding May Signal Colon Cancer: StudyStudy Finds 'No Clear Rationale' for 45% of Antibiotic PrescriptionsThere's a Virus Spreading in U.S. That's Killed 10,000: The FluSome U.S. Workers Are Bringing Toxins Home to Their KidsAHA News: Expert Heart Advice for Rare Genetic Muscle Disorder9/11 Study Shows PTSD Tied to Earlier DeathWorkers With Cluster Headaches Take Twice as Many Sick DaysMore Americans to Be Evacuated From China; 12th Coronavirus Case ReportedYoung-Onset Parkinson's May Start in the Womb, New Research SuggestsHealthy Habits Can Slide After Starting Heart Medications
Questions and AnswersLinks
Related Topics

Diabetes

Immune-Targeted Treatment Might Help Prevent Peanut Allergy Crises

HealthDay News
by By Dennis ThompsonHealthDay Reporter
Updated: Apr 8th 2019

new article illustration

MONDAY, April 8, 2019 (HealthDay News) -- Allergic reactions to peanuts can be incredibly dangerous, causing the throat to close, the chest to tighten, and throw a person into life-threatening anaphylactic shock.

But researchers now believe they've found a way to head off that immune reaction by blocking the antibodies that cause it.

There appear to be two specific allergens in peanut proteins that produce the most violent reaction from the immune system, according to the study.

A medication created to block the immune system from recognizing those allergens appeared to eliminate allergic reaction to peanuts in laboratory blood tests, researchers reported.

"Antibodies will interact with our inhibitors, and our inhibitors will not trigger the allergic reaction, it will just block the antibodies," explained senior researcher Basar Bilgicer. He's an associate professor of chemical and biomolecular engineering with the University of Notre Dame in Indiana.

It has yet to be tested in human clinical trials, but the drug could be a step up from medications like the EpiPen and antihistamines, which only subdue symptoms once the reaction has started, Bilgicer said.

Food allergies occur when a person's immune system recognizes the food as a potential threat to the body and overreacts in response.

Science has started to examine how immune antibodies interact with food to produce these reactions, Bilgicer explained.

In this case, Bilgicer and his research team took blood from 16 patients who are allergic to peanuts and started testing their antibodies to find which peanut allergens create the worst immune response.

The researchers identified two allergens that appear to be the main culprits, and then created a drug that would attach to the parts of a person's allergy-specific antibodies that interact with peanuts.

The new medication blocked allergic response in the blood of 14 of the 16 patients, researchers reported.

"It's very specific and only blocks those antibodies that are responsible for the allergic reaction," Bilgicer said. "It doesn't interfere with any other immune system responses."

The drug they've created could wind up as a pill or monthly injection people would take to ward off their peanut allergy, Bilgicer said.

It also could be used to help patients receiving immunotherapy, which involves exposing them to small amounts of peanuts to gradually reduce their immune response.

"Some patients are so allergic they are not eligible for undergoing immunotherapy," Bilgicer said. "Potentially, this could be used in combination with immunotherapy to desensitize those patients and get rid of the allergic condition for good."

The study was published April 8 in Proceedings of the National Academy of Sciences.

Allergy experts called the new research "exciting."

"Something like this, which seems to be going to where the problem occurs at the level of the recognition of the allergen, is an exciting thing," said Dr. Punita Ponda. She's assistant chief of allergy and immunology at Northwell Health in Great Neck, N.Y.

But right now this has only been tested in the lab, and Ponda said the complexity of the human immune system could create unpredictable problems in clinical trials.

For example, the immune system contains many redundancies, so blocking these specific immune receptors might cause the immune system to become more sensitive to other antigens in peanuts, Ponda said.

"We have to wait and see," Ponda said. "I think what I'm saying is, it's exciting but let's not count our chickens before they're hatched."

Dr. Edwin Kim, an assistant professor of medicine with the University of North Carolina, said he's curious how this approach might be used to help people with multiple food allergies.

He's also interested in how the immune system would respond to such a therapy long-term.

"Say you can successfully treat for a year," Kim said. "Is there some sort of feedback mechanism or something that tells the immune system, OK, look, nothing's happening, you can dial yourself down, and get a lasting effect that way? That would be pretty exciting to see."

Bilgicer said his team is now looking for funding that would allow them to pursue clinical trials.

More information

The American College of Allergy, Asthma and Immunology has more about food allergies.